EKF Diagnostics (LON:EKF) Issues Earnings Results

EKF Diagnostics (LON:EKF) announced its quarterly earnings results on Tuesday. The company reported GBX 1.38 ($0.02) earnings per share for the quarter, Digital Look Earnings reports. EKF Diagnostics had a return on equity of 7.03% and a net margin of 9.37%.

EKF Diagnostics Trading Down 2.5 %

Shares of EKF stock opened at GBX 21.45 ($0.28) on Thursday. EKF Diagnostics has a 1-year low of GBX 18.40 ($0.24) and a 1-year high of GBX 33.80 ($0.44). The company has a market cap of £95.34 million, a price-to-earnings ratio of 19.96 and a beta of 0.57. The company has a debt-to-equity ratio of 0.34, a current ratio of 4.60 and a quick ratio of 1.77. The stock has a 50 day simple moving average of GBX 23.23 and a 200-day simple moving average of GBX 25.85.

Insider Activity at EKF Diagnostics

In other news, insider Gavin T. Jones bought 50,000 shares of EKF Diagnostics stock in a transaction on Tuesday, March 25th. The stock was acquired at an average price of GBX 22 ($0.28) per share, with a total value of £11,000 ($14,162.48). 5.24% of the stock is owned by corporate insiders.

About EKF Diagnostics

EKF is an AIM-listed global diagnostics business focussed on:

● Point-of-Care analysers in the key areas of Hematology and Diabetes

● Life Sciences services provide specialist manufacture of enzymes and custom products for use in diagnostic, food and industrial applications.

EKF has headquarters in Penarth (near Cardiff) and operates five manufacturing sites across the US and Germany, selling into over 120 countries world-wide.